Best of Both Worlds: Bridging One Model for All and Group-Specific Model Approaches using Ensemble-based Subpopulation Modeling
UMass Chan Affiliations
Emergency MedicineDocument Type
Conference PaperPublication Date
2024-05-31
Metadata
Show full item recordAbstract
Subpopulation models have become of increasing interest in prediction of clinical outcomes because they promise to perform better for underrepresented patient subgroups. However, the personalization benefits gained from these models tradeoff their statistical power, and can be impractical when the subpopulation's sample size is small. We hypothesize that a hierarchical model in which population information is integrated into subpopulation models would preserve the personalization benefits and offset the loss of power. In this work, we integrate ideas from ensemble modeling, personalization, and hierarchical modeling and build ensemble-based subpopulation models in which specialization relies on whole group samples. This approach significantly improves the precision of the positive class, especially for the underrepresented subgroups, with minimal cost to the recall. It consistently outperforms one model for all and one model for each subgroup approaches, especially in the presence of a high class-imbalance, for subgroups with at least 380 training samples.Source
Mugambi P, Carreiro S. Best of Both Worlds: Bridging One Model for All and Group-Specific Model Approaches using Ensemble-based Subpopulation Modeling. AMIA Jt Summits Transl Sci Proc. 2024 May 31;2024:354-363. PMID: 38827055; PMCID: PMC11141864.Permanent Link to this Item
http://hdl.handle.net/20.500.14038/53738PubMed ID
38827055Funding and Acknowledgements
PM is funded in part by the Institute of Diversity Sciences at University of Massachusetts, Amherst, and SC is funded by NIH/NIDA (R25DA058490).Rights
Copyright ©2024 AMIA. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose.Related items
Showing items related by title, author, creator and subject.
-
Flipping Biological Switches: Solving for Optimal Control: A DissertationChang, Joshua TsuKang (2015-03-30)Switches play an important regulatory role at all levels of biology, from molecular switches triggering signaling cascades to cellular switches regulating cell maturation and apoptosis. Medical therapies are often designed to toggle a system from one state to another, achieving a specified health outcome. For instance, small doses of subpathologic viruses activate the immune system’s production of antibodies. Electrical stimulation revert cardiac arrhythmias back to normal sinus rhythm. In all of these examples, a major challenge is finding the optimal stimulus waveform necessary to cause the switch to flip. This thesis develops, validates, and applies a novel model-independent stochastic algorithm, the Extrema Distortion Algorithm (EDA), towards finding the optimal stimulus. We validate the EDA’s performance for the Hodgkin-Huxley model (an empirically validated ionic model of neuronal excitability), the FitzHugh-Nagumo model (an abstract model applied to a wide range of biological systems that that exhibit an oscillatory state and a quiescent state), and the genetic toggle switch (a model of bistable gene expression). We show that the EDA is able to not only find the optimal solution, but also in some cases excel beyond the traditional analytic approaches. Finally, we have computed novel optimal stimulus waveforms for aborting epileptic seizures using the EDA in cellular and network models of epilepsy. This work represents a first step in developing a new class of adaptive algorithms and devices that flip biological switches, revealing basic mechanistic insights and therapeutic applications for a broad range of disorders.
-
Development of transplant immunosuppressive agents - considerations in the use of animal modelsCostello, Russell; Kissenpfennig, Adrien; Martins, Paulo N.A.; McDaid, James (2018-11-01)INTRODUCTION: The development of all immunosuppressant agents to date has involved the experimental use of large and small animal models. Over the last half-century, immunosuppressive drugs have extended the lives of transplant patients worldwide. However, the use of animal models in the development of these drugs is not perfect, and this has brought to light a number of issues including idiosyncratic reactions that are found in animal models but not in humans. The 2006 highly publicized case of the 'elephant man' TGN 1412 drug trial highlights the importance of being cogent of the limitations of animal models. Areas covered: This review covers the utility and limitations of the use of animal models for the development of immunosuppressant agents. This includes both large and small animal models, particularly rodent models in the transplant setting. Expert opinion: The use of animal models represents a critical stage in the development of immunosuppressive drugs. Limitations include physiological differences to humans; this is especially true of immunologically naïve lab rodents with small memory cell populations. Toxic drug levels may differ widely between species. Animal models are also costly and raise ethical concerns. However, there is currently no way to recreate the complex environment of the human immune system purely in vitro.
-
A Bayesian model of shape and appearance for subcortical brain segmentationPatenaude, Brian; Smith, Stephen M.; Kennedy, David N; Jenkinson, Mark (2011-06-01)Automatic segmentation of subcortical structures in human brain MR images is an important but difficult task due to poor and variable intensity contrast. Clear, well-defined intensity features are absent in many places along typical structure boundaries and so extra information is required to achieve successful segmentation. A method is proposed here that uses manually labelled image data to provide anatomical training information. It utilises the principles of the Active Shape and Appearance Models but places them within a Bayesian framework, allowing probabilistic relationships between shape and intensity to be fully exploited. The model is trained for 15 different subcortical structures using 336 manually-labelled T1-weighted MR images. Using the Bayesian approach, conditional probabilities can be calculated easily and efficiently, avoiding technical problems of ill-conditioned covariance matrices, even with weak priors, and eliminating the need for fitting extra empirical scaling parameters, as is required in standard Active Appearance Models. Furthermore, differences in boundary vertex locations provide a direct, purely local measure of geometric change in structure between groups that, unlike voxel-based morphometry, is not dependent on tissue classification methods or arbitrary smoothing. In this paper the fully-automated segmentation method is presented and assessed both quantitatively, using Leave-One-Out testing on the 336 training images, and qualitatively, using an independent clinical dataset involving Alzheimer's disease. Median Dice overlaps between 0.7 and 0.9 are obtained with this method, which is comparable or better than other automated methods. An implementation of this method, called FIRST, is currently distributed with the freely-available FSL package.